Table 2.
P-values of different genes in five studies selected in Oncomine
| Critchley | Haqq | Riker | Talantov | TCGA | |
|---|---|---|---|---|---|
| YTHDF1 | 0.187 | – | – | – | 1.14 * 10−7 |
| ELF3 | 0.258 | 0.516 | 0.887 | 0.999 | 3.86 * 10−7 |
| HNRNPA2B1 | 0.814 | 1.197 | 0.062 | 0.246 | 2.64 * 10−10 |
| YTHDF2 | 0.117 | 0.392 | 0.182 | 0.020 | 0.441 |
| WTAP | 0.794 | – | 0.185 | 0.400 | 1.000 |
| METTL14 | 0.671 | – | 0.899 | – | 0.962 |
| FTO | 0.167 | 0.035 | 0.259 | 0.818 | 0.989 |
| ALKBH5 | 0.092 | 0.668 | 0.211 | – | 0.995 |
| HNRNPC | 0.200 | – | 0.322 | 2.68 * 10−5 | 0.943 |
| METTL3 | 0.349 | – | 0.074 | 0.650 | 0.944 |
The results are from comparisons of patients with melanoma and healthy individuals. Critchley, Critchley-Thorne, et al., Plos Med (2007); Haqq, Christopher Haqq, et al., PNAS(2005); Riker, Adam I Riker, et al., BMC Med Genomics (2008); Talantov, Dmitri Talantov, et al., Human cancer biology (2005); TCGA, the cancer genome atlas (2013)